These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 8282287)

  • 1. [Therapy of dementing diseases: value of calcium antagonists].
    Möller HJ
    Fortschr Med; 1993 Oct; 111(28):437-40. PubMed ID: 8282287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness and tolerance of nimodipine in long-term treatment of patients with organic brain disorders].
    Biersack K; Rosskopf R; Eckert H; Pasz T
    Z Arztl Fortbild (Jena); 1992 May; 86(9):451-6. PubMed ID: 1604901
    [No Abstract]   [Full Text] [Related]  

  • 3. Nimodipine prior to alcohol withdrawal prevents memory deficits during the abstinence phase.
    Brooks SP; Croft AP; Norman G; Shaw SG; Little HJ
    Neuroscience; 2008 Nov; 157(2):376-84. PubMed ID: 18835336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nimodipine plus zidovudine versus zidovudine alone in the treatment of HIV-1-associated cognitive deficits.
    Galgani S; Balestra P; Narciso P; Tozzi V; Sette P; Pau F; Visco G
    AIDS; 1997 Oct; 11(12):1520-1. PubMed ID: 9342076
    [No Abstract]   [Full Text] [Related]  

  • 5. [Altered calcium homeostasis in brain aging and senile dementia, new approach to treat Alzheimer's disease].
    Zhang JT
    Yao Xue Xue Bao; 1993; 28(9):641-6. PubMed ID: 8010007
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment with nootropic drugs].
    Barocka A
    Fortschr Med; 1990 Mar; 108(9):178-80. PubMed ID: 2187782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in calcium antagonist receptors and calcium content in senescent brain and attenuation by nimodipine and nicardipine.
    Yamada S; Uchida S; Ohkura T; Kimura R; Yamaguchi M; Suzuki M; Yamamoto M
    J Pharmacol Exp Ther; 1996 May; 277(2):721-7. PubMed ID: 8627551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical findings with nimodipine in dementia: test of the calcium hypothesis.
    Fritze J; Walden J
    J Neural Transm Suppl; 1995; 46():439-53. PubMed ID: 8821080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
    Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
    Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dementing disorders. What benefits do the new anti-dementia drugs have?].
    Ihl R
    MMW Fortschr Med; 2002 May; Suppl 2():24-6, 28-9. PubMed ID: 12070846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo uptake of [3H]nimodipine into brain during cortical spreading depression.
    Osuga S; Hakim AM; Osuga H; Hogan MJ
    J Cereb Blood Flow Metab; 1997 May; 17(5):586-90. PubMed ID: 9183298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Objective psychometric tests in clinical trials of dementia drugs. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines.
    Ferris SH; Lucca U; Mohs R; Dubois B; Wesnes K; Erzigkeit H; Geldmacher D; Bodick N
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 3():34-8. PubMed ID: 9305514
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy approaches in cerebral cognitive deficits--neuropsychiatric aspects].
    Reisecker F
    Wien Med Wochenschr; 1996; 146(21-22):546-8. PubMed ID: 9092214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Brain aging and calcium antagonist drugs. A preliminary open study with nimodipine].
    Centonze V; Massaro C; Polito BM; Cassiano MA; Di Bari M; Russo P; Cirillo L; Albano O
    Clin Ter; 1992 Jan; 140(1):11-5. PubMed ID: 1526092
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase prevention in bipolar affective disorder with nimodipine. A case report].
    Hesslinger B; Riedel H; Hellwig B; Walden J; Berger M
    Nervenarzt; 1996 May; 67(5):394-6. PubMed ID: 9005349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Feasibility and safety of intrathecal nimodipine on posthaemorrhagic cerebral vasospasm refractory to medical and endovascular therapy.
    Hänggi D; Beseoglu K; Turowski B; Steiger HJ
    Clin Neurol Neurosurg; 2008 Sep; 110(8):784-90. PubMed ID: 18554777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium channel blockers and dementia.
    Nimmrich V; Eckert A
    Br J Pharmacol; 2013 Jul; 169(6):1203-10. PubMed ID: 23638877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recommendations for clinical trials of drugs indicated for dementing diseases].
    Nervenarzt; 1991 Apr; 62(4):256-9. PubMed ID: 1857461
    [No Abstract]   [Full Text] [Related]  

  • 19. [The use of nimodipine in elderly dementia patients].
    Damulin IV; Levin OS; Zakharov VV; Zhuchenko TD; Elkin MN
    Ter Arkh; 1995; 67(10):77-9. PubMed ID: 8779117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroanatomic and neurophysiologic changes in the aging brain.
    Kelly KM
    Geriatrics; 2005 May; Suppl():4-6, 19. PubMed ID: 16025881
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.